GlassScriptPhysician profile
Amish A Patel
NPI 1083938906
$7,381.98
in general payments reported to CMS, 2019-2025
37 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,474 · 2020: $249 · 2021: $1,294 · 2022: $1,115 · 2023: $977 · 2024: $1,083 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,150 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,149.58 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $806.59 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $792.46 | 2021-2025 | |
| Amgen INC. | $578.36 | 2020-2025 | Repatha, Repatha |
| Abiomed | $543.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $487.89 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $474.67 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $462.01 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $379.80 | 2019-2024 | Xarelto |
| Asahi Intecc USA, INC. | $357.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $270.93 | 2021-2025 | Farxiga, Wainua |
| Actelion Pharmaceuticals US, INC. | $269.78 | 2021-2024 | Opsumit, Uptravi |
| Abbott Laboratories | $255.35 | 2019-2024 | Aveir |
| Esperion Therapeutics, INC. | $192.05 | 2020-2023 | Nexletol |
| Novo Nordisk INC | $152.50 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Medtronic USA, INC. | $152.43 | 2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $138.23 | 2021-2025 | Watchman Flx, Varithena Administration Pack |
| Kestra Medical Technology Services, INC. | $130.87 | 2022-2025 | Assure Wcd |
| Allergan, INC. | $125.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $104.91 | 2024 | |
| Phathom Pharmaceuticals, INC. | $93.23 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $77.22 | 2022-2023 | Verquvo |
| Amarin Pharma, INC. | $74.72 | 2020-2021 | |
| Cleerly, INC. | $63.63 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $52.30 | 2021-2022 | |
| Sobi, INC | $50.19 | 2022 | |
| Biodelivery Sciences International, INC. | $44.99 | 2019-2021 | |
| Inspire Medical Systems, INC. | $39.06 | 2024-2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $37.44 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $23.42 | 2024 | Arcalyst |
| Itamar Medical INC | $21.95 | 2022 | |
| Irhythm Technologies, INC. | $20.91 | 2023 | Zio Xt Patch |
| Medtronic Vascular, INC. | $20.60 | 2019 | |
| United Therapeutics Corporation | $20.18 | 2023 | Remodulin |
| Pulmonx Corporation | $19.36 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Akcea Therapeutics, INC. | $17.24 | 2020 | |
| Atricure, INC. | $15.66 | 2021 | |
| Heartflow, INC. | $14.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.